In a report published on Tuesday, Canaccord Genuity analyst Jason R. Mills downgraded Intuitive Surgical ISRG from Buy to Hold and lowered the price target from $527 to $444.
In the report, Canaccord Genuity noted, "However, Q2 results usurped our most bearish scenario; represented ISRG's worst system placement performance (-6% Y/Y) since the height of the financial crisis in Q3/09; and most notably, exhibited a significant deviation from historic growth trends – ISRG had reported system sales growth >15% for 9 consecutive quarters".
Intuitive Surgical closed on Monday at $500.08.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.